US 12005069
Bortezomib compositions
granted A61KA61K31/198A61K31/4439
Quick answer
US patent 12005069 (Bortezomib compositions) held by MAIA PHARMACEUTICALS, INC. expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MAIA PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/198, A61K31/4439, A61K31/573, A61K31/69